Avalyn Pharma
Avalyn is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). While existing therapeutic options slow disease progression, their significant side effects often limit patient’s persistence and compliance with the drugs. We are dedicated to making a meaningful impact in the lives of patients. Our goal is to deliver inhaled formulations of effective medicines directly to lung tissue, thus potentially enhancing efficacy and avoiding side effects associated with systemic drug delivery.Learn more about this approach and our therapeutic focus.Content by Avalyn Pharma
| 7 min read
Synthetic control arms are emerging as a valuable solution for clinical trials where using traditional placebo groups is difficult, unethical, or impractical.
Page 1 of 1 - 1 Total Items
